Norio Wada

2.2k total citations
53 papers, 637 citations indexed

About

Norio Wada is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Norio Wada has authored 53 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Norio Wada's work include Hormonal Regulation and Hypertension (31 papers), Adrenal and Paraganglionic Tumors (27 papers) and Adrenal Hormones and Disorders (17 papers). Norio Wada is often cited by papers focused on Hormonal Regulation and Hypertension (31 papers), Adrenal and Paraganglionic Tumors (27 papers) and Adrenal Hormones and Disorders (17 papers). Norio Wada collaborates with scholars based in Japan, United States and Greece. Norio Wada's co-authors include Narihito Yoshioka, Takao Koike, Hiromichi Kijima, Mika Tsuiki, Mitsumasa Kubo, Takamasa Ichijo, Mitsuhide Naruse, Ryuichi Sakamoto, Hironobu Umakoshi and Hitoshi Chiba and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Scientific Reports.

In The Last Decade

Norio Wada

50 papers receiving 629 citations

Peers

Norio Wada
Susanne Crowe United States
Curtis Rambaran United Kingdom
Paul Hollington Australia
Anna Piva Italy
Susanne Crowe United States
Norio Wada
Citations per year, relative to Norio Wada Norio Wada (= 1×) peers Susanne Crowe

Countries citing papers authored by Norio Wada

Since Specialization
Citations

This map shows the geographic impact of Norio Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norio Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norio Wada more than expected).

Fields of papers citing papers by Norio Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norio Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norio Wada. The network helps show where Norio Wada may publish in the future.

Co-authorship network of co-authors of Norio Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Norio Wada. A scholar is included among the top collaborators of Norio Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norio Wada. Norio Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakano, Eriko, Kosuke Mukai, Atsunori Fukuhara, et al.. (2024). Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation. Endocrine Journal. 71(5). 489–497.
2.
Wada, Norio, et al.. (2023). Prolonged postoperative hypoaldosteronism related to hyperkalemia in patients with aldosterone-producing adenoma. Endocrine Journal. 70(9). 917–924. 1 indexed citations
3.
Kitamoto, Takumi, Tsuyoshi Idé, Yuta Tezuka, et al.. (2023). Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study. Scientific Reports. 13(1). 21722–21722. 1 indexed citations
4.
Wada, Norio, et al.. (2023). A case of subacute thyroiditis after influenza vaccination. Endocrinology Diabetes and Metabolism Case Reports. 2023(1).
5.
Umakoshi, Hironobu, Norio Wada, Takamasa Ichijo, et al.. (2022). Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?. Clinical Endocrinology. 98(4). 473–480. 1 indexed citations
6.
Kameda, Hiraku, Hiroshi Nomoto, Kyu Yong Cho, et al.. (2021). Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study. Journal of Diabetes Investigation. 12(11). 1978–1982. 6 indexed citations
7.
Umakoshi, Hironobu, Masatoshi Ogata, Norio Wada, et al.. (2021). Machine learning based models for prediction of subtype diagnosis of primary aldosteronism using blood test. Scientific Reports. 11(1). 9140–9140. 19 indexed citations
8.
Yano, Yuichiro, Yu Hatano, Kouichi Tamura, et al.. (2021). Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function. Journal of Human Hypertension. 36(10). 904–910. 4 indexed citations
9.
Nishimoto, Koshiro, Hironobu Umakoshi, Tsugio Seki, et al.. (2021). Diverse pathological lesions of primary aldosteronism and their clinical significance. Hypertension Research. 44(5). 498–507. 4 indexed citations
10.
Hirawa, Nobuhito, Yuichiro Yano, Kouichi Tamura, et al.. (2021). Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis. 324. 84–90. 13 indexed citations
11.
Umakoshi, Hironobu, Masatoshi Ogata, Maki Yokomoto‐Umakoshi, et al.. (2020). Significance of Discordant Results Between Confirmatory Tests in Diagnosis of Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 106(2). e866–e874. 13 indexed citations
12.
Ogata, Masatoshi, Hironobu Umakoshi, Yayoi Matsuda, et al.. (2020). Significance of aldosterone gradient within left adrenal vein in diagnosing unilateral subtype of primary aldosteronism. Clinical Endocrinology. 94(1). 24–33. 3 indexed citations
13.
Kawaharada, Mariko, et al.. (2017). Development and validation of an educational program to enhance sense of coherence in patients with diabetes mellitus type 2.. PubMed. 79(3). 363–374. 21 indexed citations
14.
Fujii, Yuichi, Hironobu Umakoshi, Norio Wada, et al.. (2017). Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling. Journal of Human Hypertension. 32(1). 12–19. 9 indexed citations
15.
Wada, Norio, Yuki Shibayama, Hironobu Umakoshi, et al.. (2017). Hyperkalemia in both surgically and medically treated patients with primary aldosteronism. Journal of Human Hypertension. 31(10). 627–632. 13 indexed citations
16.
Kamemura, Kohei, Norio Wada, Takamasa Ichijo, et al.. (2016). Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism. Journal of Human Hypertension. 31(3). 195–199. 26 indexed citations
17.
Wada, Norio, M Sekiguchi, Narihito Yoshioka, et al.. (2005). Effect of Probucol and Pravastatin on Common-carotid Atherosclerosis in Diabetic Patients with Hypercholesterolemia. 48(1). 53–56. 1 indexed citations
18.
Ieko, Masahiro, Kenichi Sawada, Takao Koike, et al.. (1999). The Putative Mechanism of Thrombosis in Antiphospholipid Syndrome: Impairment of the Protein C and the Fibrinolytic Systems by Monoclonal Anticardiolipin Antibodies. Seminars in Thrombosis and Hemostasis. 25(5). 503–508. 27 indexed citations
19.
Yanagawa, Tatsuo, Yuichi Yoshida, Norio Wada, et al.. (1997). Blood pressure, insulin, and haematocrit values in Japanese subjects over 60 years of age. Journal of Human Hypertension. 11(6). 355–359. 1 indexed citations
20.
Wada, Norio, Hitoshi Chiba, Chikara Shimizu, et al.. (1997). A Novel Missense Mutation in Codon 218 of the Albumin Gene in a Distinct Phenotype of Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Kindred. The Journal of Clinical Endocrinology & Metabolism. 82(10). 3246–3250. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026